27 results on '"Bogdanovska S"'
Search Results
2. RENAL DYSFUNCTION ASSOCIATED WITH HYPERTENSION IN PREDISPOSED SUBJECTS: P87
- Author
-
Lozance, Lj., Zafirovska, K., Bogdanovska, S., Gerasimovska-Kitanovska, B., and Severova, G.
- Published
- 2009
3. NIGHT DIPPING AND MESOR ANALYSIS OF 24-HOUR BLOOD PRESSURE MONITORING IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND PATIENTS WITH ESSENTIAL HYPERTENSION: P44
- Author
-
Gerasimovska-Kitanovska, B., Zafirovska, K., Bogdanovska, S., and Lozance, Lj.
- Published
- 2009
4. Investigation of the Diagnostic Performance of Dimethyl Arginine Derivate and Lisosomal Enzymes in Patients with Rheumatoid Arthritis
- Author
-
Gjorcev A, Bogdanovska S, D. Spasovski, Grcevska L, Alabakovska S, Chaparovska D, S. Genadieva-Stavric, Jankulovski N, Sadicario S, T. Sotirova, and Bozinovski G
- Subjects
Pathology ,medicine.medical_specialty ,business.industry ,Arthritis ,Urine ,urologic and male genital diseases ,medicine.disease ,Asymptomatic ,Gastroenterology ,Rheumatoid arthritis ,Internal medicine ,Direct agglutination test ,medicine ,Rheumatoid factor ,Microalbuminuria ,medicine.symptom ,business ,Immunoturbidimetry - Abstract
Introduction: Untreated Rheumatoid Arthritis (RA) has implications on renal tissue as one of the visceral manifestations of disease. Arthritis primarily damages the proximal renal tubules. Aim: To compare the diagnostic values of laboratory variables; to find the predictive value of the positive and negative test and accuracy of the tests for Symmetric Dimethyl Arginine (SDMA), N-acetyl-β-D-glucosaminidase (NAG), microalbuminuria, rheumatoid factor (RF), C-reactive protein (CRP) andDisease Activity Score 28 index (DAS 28); and to detect the effect of untreated rheumatoid arthritis on glomerular and tubular function. Patients and methods: Quantification of N-acetyl-β-D-glucosaminidase is used for colorimetric assay, ELISA method for detection of SDMA, immunoturbidimetry assay for microalbuminuria and agglutination test for RF. Serum and urine simples are examined in 70 participants (35 patients with untreated rheumatoid arthritis and 35 healthy individuals as control group). Results: Of 35 examined patients with RA, we found presence of NAG enzymuria (sensitivity of the test; 37.14%) in 13, while microalbuminuria appeared in 4 patients (sensitivity of the test; 11.42%). SDMA was present in 26 patients (sensitivity of the test; 74.58%), while RF was detected in 17 patients (sensitivity of the test; 48.57%). Conclusion: SDMA and NAG have higher sensitivity than microalbuminuria in the detection of asymptomatic renal impairment in untreated RA.
- Published
- 2014
- Full Text
- View/download PDF
5. PREGNANCY AND THE KIDNEY
- Author
-
Stoumpos, S., primary, McNeill, S. H., additional, McPherson, K., additional, Gorrie, M., additional, Mark, P. B., additional, Brennand, J. E., additional, Geddes, C. C., additional, Deighan, C. J., additional, Gerasimovska Kitanovska, B., additional, Zafirovska, K., additional, Bogdanovska, S., additional, Gerasimovska, V., additional, and Sikole, A., additional
- Published
- 2014
- Full Text
- View/download PDF
6. Extracorporeal dialysis: techniques and adequacy
- Author
-
Donadio, C., primary, Kanaki, A., additional, Martin-Gomez, A., additional, Garcia, S., additional, Palacios-Gomez, M., additional, Donadio, C., additional, Calia, D., additional, Colombini, E., additional, DI Francesco, F., additional, Ghimenti, S., additional, Onor, M., additional, Tognotti, D., additional, Fuoco, R., additional, Marka-Castro, E., additional, Torres Zamora, M. I., additional, Giron-Mino, J., additional, Jaime-Solis, M. A., additional, Arteaga, L. M., additional, Romero, H., additional, Akonur, A., additional, Leypoldt, K., additional, Asola, M., additional, Culleton, B., additional, Eloot, S., additional, Glorieux, G., additional, Nathalie, N., additional, Vanholder, R., additional, Perez de Jose, A., additional, Verdalles Guzman, U., additional, Abad Esttebanez, S., additional, Vega Martinez, A., additional, Barraca, D., additional, Yuste, C., additional, Bucalo, L., additional, Rincon, A., additional, Lopez-Gomez, J. M., additional, Bataille, P., additional, Celine, P., additional, Raymond, A., additional, Francois, G., additional, Herve, L., additional, Michel, D., additional, Jean Louis, R., additional, Zhu, F., additional, Kotanko, P., additional, Thijssen, S., additional, Levin, N. W., additional, Papamichail, N., additional, Bougiakli, M., additional, Gouva, C., additional, Antoniou, S., additional, Gianitsi, S., additional, Vlachopanou, A., additional, Chachalos, S., additional, Naka, K., additional, Kaarsavvidou, D., additional, Katopodis, K., additional, Michalis, L., additional, Sasaki, K., additional, Yasuda, K., additional, Yamato, M., additional, Surace, A., additional, Rovatti, P., additional, Steckiph, D., additional, Bandini, R., additional, Severi, S., additional, Dellacasa Bellingegni, A., additional, Santoro, A., additional, Arias, M., additional, Sentis, A., additional, Perez, N., additional, Fontsere, N., additional, Vera, M., additional, Rodriguez, N., additional, Arcal, C., additional, Ortega, N., additional, Uriza, F., additional, Cases, A., additional, Maduell, F., additional, Abbas, S. R., additional, Georgianos, P., additional, Sarafidis, P., additional, Nikolaidis, P., additional, Lasaridis, A., additional, Ahmed, A., additional, Kaoutar, H., additional, Mohammed, B., additional, Zouhir, O., additional, Balter, P., additional, Ginsberg, N., additional, Taylor, P., additional, Sullivan, T., additional, Usvyat, L. A., additional, Zabetakis, P., additional, Moissl, U., additional, Ferrario, M., additional, Garzotto, F., additional, Wabel, P., additional, Cruz, D., additional, Tetta, C., additional, Signorini, M. G., additional, Cerutti, S., additional, Brendolan, A., additional, Ronco, C., additional, Heaf, J., additional, Axelsen, M., additional, Pedersen, R. S., additional, Amine, H., additional, Oualim, Z., additional, Ammirati, A. L., additional, Guimaraes de Souza, N. K., additional, Nemoto Matsui, T., additional, Luiz Vieira, M., additional, Alves de Oliveira, W. A., additional, Fischer, C. H., additional, Dias Carneiro, F., additional, Iizuka, I. J., additional, Aparecida de Souza, M., additional, Mallet, A. C., additional, Cruz Andreoli, M. C., additional, Cardoso Dos Santos, B. F., additional, Rosales, L., additional, Dou, Y., additional, Carter, M., additional, Testa, A., additional, Sottini, L., additional, Giacon, B., additional, Prati, E., additional, Loschiavo, C., additional, Brognoli, M., additional, Marseglia, C., additional, Tommasi, A., additional, Sereni, L., additional, Palladino, G., additional, Bove, S., additional, Bosticardo, G., additional, Schillaci, E., additional, Detoma, P., additional, Bergia, R., additional, Park, J. W., additional, Moon, S. J., additional, Choi, H. Y., additional, Ha, S. K., additional, Park, H.-C., additional, Liao, Y., additional, Zhang, L., additional, Fu, P., additional, Igarashi, H., additional, Suzuki, N., additional, Esashi, S., additional, Masakane, I., additional, Panichi, V., additional, De Ferrari, G., additional, Saffiotti, S., additional, Sidoti, A., additional, Biagioli, M., additional, Bianchi, S., additional, Imperiali, P., additional, Gabrielli, C., additional, Conti, P., additional, Patrone, P., additional, Rombola, G., additional, Falqui, V., additional, Mura, C., additional, Icardi, A., additional, Rosati, A., additional, Santori, F., additional, Mannarino, A., additional, Bertucci, A., additional, Jeong, J., additional, Kim, O. K., additional, Kim, N. H., additional, Bots, M., additional, Den Hoedt, C., additional, Grooteman, M. P., additional, Van der Weerd, N. C., additional, Mazairac, A. H. A., additional, Levesque, R., additional, Ter Wee, P. M., additional, Nube, M. J., additional, Blankestijn, P., additional, Van den Dorpel, M. A., additional, Park, Y., additional, Jeon, J., additional, Tessitore, N., additional, Bedogna, V., additional, Girelli, D., additional, Corazza, L., additional, Jacky, P., additional, Guillaume, Q., additional, Julien, B., additional, Marcinkowski, W., additional, Drozdz, M., additional, Milkowski, A., additional, Rydzynska, T., additional, Prystacki, T., additional, August, R., additional, Benedyk-Lorens, E., additional, Bladek, K., additional, Cina, J., additional, Janiszewska, G., additional, Kaczmarek, A., additional, Lewinska, T., additional, Mendel, M., additional, Paszkot, M., additional, Trafidlo, E., additional, Trzciniecka-Kloczkowska, M., additional, Vasilevsky, A., additional, Konoplev, G., additional, Lopatenko, O., additional, Komashnya, A., additional, Visnevsky, K., additional, Gerasimchuk, R., additional, Neivelt, I., additional, Frorip, A., additional, Vostry, M., additional, Racek, J., additional, Rajdl, D., additional, Eiselt, J., additional, Malanova, L., additional, Pechter, U., additional, Selart, A., additional, Ots-Rosenberg, M., additional, Krieter, D. H., additional, Seidel, S., additional, Merget, K., additional, Lemke, H.-D., additional, Wanner, C., additional, Canaud, B., additional, Rodriguez, A., additional, Morgenroth, A., additional, Von Appen, K., additional, Dragoun, G.-P., additional, Fluck, R., additional, Fouque, D., additional, Lockridge, R., additional, Motomiya, Y., additional, Uji, Y., additional, Hiramatsu, T., additional, Ando, Y., additional, Furuta, M., additional, Kuragano, T., additional, Kida, A., additional, Yahiro, M., additional, Otaki, Y., additional, Hasuike, Y., additional, Nonoguchi, H., additional, Nakanishi, T., additional, Sain, M., additional, Kovacic, V., additional, Ljutic, D., additional, Radic, J., additional, Jelicic, I., additional, Yalin, S. F., additional, Trabulus, S., additional, Yalin, A. S., additional, Altiparmak, M. R., additional, Serdengecti, K., additional, Ohtsuka, A., additional, Fukami, K., additional, Ishikawa, K., additional, Ando, R., additional, Kaida, Y., additional, Adachi, T., additional, Sugi, K., additional, Okuda, S., additional, Nesterova, O. B., additional, Suglobova, E. D., additional, Golubev, R. V., additional, Vasiliev, A. N., additional, Lazeba, V. A., additional, Smirnov, A. V., additional, Arita, K., additional, Kihara, E., additional, Maeda, K., additional, Oda, H., additional, Doi, S., additional, Masaki, T., additional, Hidaka, S., additional, Ishioka, K., additional, Oka, M., additional, Moriya, H., additional, Ohtake, T., additional, Nomura, S., additional, Kobayashi, S., additional, Wagner, S., additional, Gmerek, A., additional, Wagner, J., additional, Wizemann, V., additional, Eftimovska - Otovic, N., additional, Spaseska-Gjurovska, K., additional, Bogdanovska, S., additional, Babalj - Banskolieva, E., additional, Milovanceva, M., additional, Grozdanovski, R., additional, Pisani, A., additional, Riccio, E., additional, Mancini, A., additional, Ambuhl, P., additional, Astrid, S., additional, Ivana, P., additional, Martin, H., additional, Thomas, K., additional, Hans-Rudolf, R., additional, Daniel, A., additional, Denes, K., additional, Marco, M., additional, Wuthrich, R. P., additional, Andreas, S., additional, Andrulli, S., additional, Altieri, P., additional, Sau, G., additional, Bolasco, P., additional, Pedrini, L. A., additional, Basile, C., additional, David, S., additional, Feriani, M., additional, Nebiolo, P. E., additional, Ferrara, R., additional, Casu, D., additional, Logias, F., additional, Tarchini, R., additional, Cadinu, F., additional, Passaghe, M., additional, Fundoni, G., additional, Villa, G., additional, DI Iorio, B. R., additional, Zoccali, C., additional, Locatelli, F., additional, Hamamoto, M., additional, Lee, D.-Y., additional, Kim, B., additional, Moon, K. H., additional, LI, Z., additional, Ahrenholz, P., additional, Winkler, R. E., additional, Waitz, G., additional, Wolf, H., additional, Grundstrom, G., additional, Alquist, M., additional, Holmquist, M., additional, Christensson, A., additional, Bjork, P., additional, Abdgawad, M., additional, Ekholm, L., additional, Segelmark, M., additional, Corsi, C., additional, De Bie, J., additional, Mambelli, E., additional, Mortara, D., additional, Arroyo, D., additional, Panizo, N., additional, Quiroga, B., additional, Reque, J., additional, Melero, R., additional, Rodriguez-Ferrero, M., additional, Rodriguez-Benitez, P., additional, Anaya, F., additional, Luno, J., additional, Ragon, A., additional, James, A., additional, Brunet, P., additional, Ribeiro, S., additional, Faria, M. S., additional, Rocha, S., additional, Rodrigues, S., additional, Catarino, C., additional, Reis, F., additional, Nascimento, H., additional, Fernandes, J., additional, Miranda, V., additional, Quintanilha, A., additional, Belo, L., additional, Costa, E., additional, Santos-Silva, A., additional, Arund, J., additional, Tanner, R., additional, Fridolin, I., additional, Luman, M., additional, Clajus, C., additional, Kielstein, J. T., additional, Haller, H., additional, Libutti, P., additional, Lisi, P., additional, Vernaglione, L., additional, Casucci, F., additional, Losurdo, N., additional, Teutonico, A., additional, Lomonte, C., additional, Krisp, C., additional, Wolters, D. A., additional, Matsuyama, M., additional, Tomo, T., additional, Ishida, K., additional, Matsuyama, K., additional, Nakata, T., additional, Kadota, J., additional, Caiazzo, M., additional, Monari, E., additional, Cuoghi, A., additional, Bellei, E., additional, Bergamini, S., additional, Tomasi, A., additional, Baranger, T., additional, Seniuta, P., additional, Berge, F., additional, Drouillat, V., additional, Frangie, C., additional, Rosier, E., additional, Labonia, W., additional, Lescano, A., additional, Rubio, D., additional, Von der Lippe, N., additional, Jorgensen, J. A., additional, Osthus, T. B., additional, Waldum, B., additional, Os, I., additional, Bossola, M., additional, DI Stasio, E., additional, Antocicco, M., additional, Tazza, L., additional, Griveas, I., additional, Karameris, A., additional, Pasadakis, P., additional, Savica, V., additional, Santoro, D., additional, Saitta, S., additional, Tigano, V., additional, Bellinghieri, G., additional, Gangemi, S., additional, Daniela, R., additional, Checherita, I. A., additional, Ciocalteu, A., additional, Vacaroiu, I. A., additional, Niculae, A., additional, Stefaniak, E., additional, Pietrzak, I., additional, Krupa, D., additional, Garred, L., additional, Mancini, E., additional, Corrazza, L., additional, Atti, M., additional, Afsar, B., additional, Stamopoulos, D., additional, Mpakirtzi, N., additional, Gogola, B., additional, Zeibekis, M., additional, Stivarou, D., additional, Panagiotou, M., additional, Grapsa, E., additional, Vega Vega, O., additional, Barraca Nunez, D., additional, Fernandez-Lucas, M., additional, Gomis, A., additional, Teruel, J. L., additional, Elias, S., additional, Quereda, C., additional, Hignell, L., additional, Humphrey, S., additional, Pacy, N., additional, and Afentakis, N., additional
- Published
- 2012
- Full Text
- View/download PDF
7. PLASMA RENIN ACTIVITY, ALDOSTERON AND PARATHYROID HORMONE IN PREDICTING THE DEVELOPMENT OF PREGNANCY INDUCED HYPERTENSION
- Author
-
Zafirovska, K., primary, Maleska, V., additional, Lozance, L. J., additional, Gerasimovska, B., additional, and Bogdanovska, S., additional
- Published
- 2004
- Full Text
- View/download PDF
8. PLASMA VISCOSITY IN PREGNANCY INDUCED HYPERTENSION
- Author
-
Zafirovska, K. G., primary, Lozance, Lj. A., additional, Bogdanovska, S. V., additional, Malevska, V. T., additional, Gerasimovska, B. D., additional, and Masin-Paneva, J., additional
- Published
- 2000
- Full Text
- View/download PDF
9. THE VALUE OF FIBRONECTIN AND FIBRINOGEN IN PREGNANCY INDUCED HYPERTENSION
- Author
-
Paneva-Masin, J., primary, Zafirovska, K., additional, Bogdanovska, S., additional, Lozance, L j., additional, Malevska, V., additional, Gerasimovska, B., additional, and Tofoski, J., additional
- Published
- 2000
- Full Text
- View/download PDF
10. CALCIUM URINARY EXCRETION IN RELATION WITH PROSTAGLANDINS AND PARATHYROID HORMONE IN PREECLAMPSIA
- Author
-
Lozance, L j., primary, Zafirovska, K., additional, Bogdanovska, S., additional, Gerasimovska, B., additional, Dzikov, Z., additional, Malevska, V., additional, and Vaskova, O., additional
- Published
- 2000
- Full Text
- View/download PDF
11. ROLE OF THE NITRIC OXIDE IN THE GENESIS OF PREGNANCY-INDUCED HYPERTENSION
- Author
-
Gerasimovska, B., primary, Zafirovska, K., additional, Bogdanovska, S., additional, Maleska, V., additional, Dejanova, B., additional, Lozance, Lj., additional, and Paneva-Masin, J., additional
- Published
- 2000
- Full Text
- View/download PDF
12. Plasma human atrial natriuretic peptide, endothelin-1, aldosterone and plasma-renin activity in pregnancy-induced hypertension.
- Author
-
Zafirovska KG, Maleska VT, Bogdanovska SV, Lozance LA, Masin-Paneva J, Gerasimovska BD, Zafirovska, K G, Maleska, V T, Bogdanovska, S V, Lozance, L A, Masin-Paneva, J, and Gerasimovska, B D
- Published
- 1999
- Full Text
- View/download PDF
13. Dialysis in Adults in Year 2000 in the Republic of Macedonia
- Author
-
Polenakovic, M.H., Sikole, A., Grozdanovski, R., Amitov, V., Stojkovski, Lj., Oncevski, A., Grcevska, L., Dzikova, S., Cakalaroski, K., Bogdanovska, S., Gerasimovska, V., Gerasimovska, B., Milovanceva, M., Stojceva-Taneva, O., Krstanovski, B., Kovaceski, S., Serijat, M., Mustafa, Z., Capova, O., Bajalska, A., Nikolovski, A., Filipovic, R., Neskovski, J., Selja, Lj., Janakievska, P., Lamova, K., Hristova, V., Sarajlija, E. Karceva, Romeo, M., Mitrevski, Z., Ivanovski, K., Dimitrov, S., Velinova, B., and Panova, B.
- Abstract
1,019 adult patients with terminal renal failure were treated with dialysis (D) in the first part of the year 2000 in the Republic of Macedonia. 1,010 patients (99%) were treated with chronic intermittent (maintenance) hemodialysis (HD) while nine patients (1%) were on continuous ambulatory peritoneal dialysis (CAPD). For the children, a special peritoneal dialysis program was developed; 509 patients per million of the population (PMP) were on dialysis.The Republic of Macedonia is, therefore, among those central and eastern European countries with a higher PMP number in the treatment of end-stage renal disease, following Croatia, the Czech Republic and Slovenia.The patients were treated at 18 Centers in a network of HD Centers at a distance of 30–50 km. from their place of residence in order to facilitate their access to treatment and to work. All patients who have had symptoms indicating need for treatment with D were accepted for treatment. The government payed all the expenses of the treatment and the salaries of the staff. 56% were male and 44% were female patients. The youngest patient was aged 9 and the oldest was 82 years old. There has been an increase in the age of the patients on D as well as an increase in their number. In 1993 we had 727 patients being treated with D, and now we have 1,019 with a constant increase in the number of patients with ESRD and a need for D and renal transplantation. Mortality per year at the different Centers ranged from 8–19% in 1999 and the average is 12%.Glomerulonephritis (GN) – both primary and secondary – is the main cause of renal failure (RF) in some Centers up to 45%. Tubulo-interstitial disease follows GN. ADPKD patients constitute 9.4% with a difference among the Centers of 3–29%, and diabetic nephropathy is found in 10%, 5–15% in different Centers. 11–61% of patients have an unknown etiology.352 patients are on treatment with human recombinant erythropoietin (rhuEPO) – in some Centers up to 60%. The mode of application was subcutaneous and the initial dose is 20 U/kg body weight and the mean maintenance dose of EPO per patient weekly is 4,000 U.The Cimino-Brescia arteriovenous fistula is being applied as a standard vascular access. The survival rate of our patients treated with maintenance HD at 5 years was 58%. CAPD and particularly renal transplantation are to be further developed as alternative methods in treating terminal renal failure.
- Published
- 2002
- Full Text
- View/download PDF
14. Association between Sharp's radiographic index and acute phase reactants in rheumatoid arthritis
- Author
-
Kafeđiska Irena, Spasovski Dejan, Gruev Todor, Marina Nada, Grličkov Mane, Čalovski Jordan, Sotirova Tatjana, Karanfilski Oliver, and Bogdanovska Stefka
- Subjects
rheumatoid arthritis ,sharp's radiographic index ,acute phase reactants ,Biochemistry ,QD415-436 - Abstract
The aim of this study was to evaluate the activity of rheumatoid arthritis (RA) by hand radiography (Sharp's radiographic index), and assessment of acute phase reactants - erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and rheumatoid factor (RF), and to determine their value as prognostic markers for disease outcome in patients with early RA treated with disease modifying antirheumatic drugs (DMARDs)-Methotrexate (MTH); to register and quantify clinical, radiographic and laboratorial differences in certain time intervals in a group of patients treated with immunomodulation therapy with MTH; to determine which of the acute phase reactants would be the most useful marker for evaluation of disease activity in long-term follow-up in RA patients; to select high-risk groups with aggressive course of disease, in order to emphasize the necessity of early and aggressive treatment. Thirty patients with early RA (disease evolution up to 1 year) were evaluated in several time intervals. The score of the Sharp's index showed greater radiographic progression of the joint damage of hands in time intervals between 0-time and 12 months (p=0.0167) and between 0-time and 18 months (p=0.0089). Statistical analysis showed differences in values of CRP in four time intervals (p=0.00002). Considering CRP, there were statistically significant differences among mean values in four time intervals (p=0.0428) (standard deviations showed greater variations). There were no statistically significant differences among mean values of RF in four time intervals (p=0.573). At 0-time in 3 (10%) patients progression of the Sharp's index was found, after 6 months in 13 (39%) patients, while after 12 and 18 months progression of the Sharp's index was found in an identical number of patients, 15 (50%). In most patients high values of CRP and RF were found. Progression of the radiographic damage is especially expressed in patients with high values of ESR, CRP, RF and existence of previous erosions of hands, which are predictors for aggressive course of disease. CRP is the most useful marker for the evaluation of RA activity in the long-term follow-up of RA patients.
- Published
- 2008
15. ROLE OF THE NITRIC OXIDE IN THE GENESIS OF PREGNANCYINDUCED HYPERTENSION
- Author
-
Gerasimovska, B., Zafirovska, K., Bogdanovska, S., Maleska, V., Dejanova, B., Lozance, Lj., and Paneva-Masin, J.
- Published
- 2000
16. Pheochromocytoma and Neurofibromatosis Type 1 in a Patient with Hypertension.
- Author
-
Petrovska J, Kitanovska BG, Bogdanovska S, and Kuzmanoska SP
- Abstract
Background: Neurofibromatosis type 1 is an autosomal dominant condition that has a variety of clinical manifestations. Essential or secondary hypertension may be associated with neurofibromatosis. A rare finding is hypertension due to pheochromocytoma in patient with neurofibromatosis type 1., Case Report: We present a case with a 7-year medical history of hypertension which was poorly controlled and with wide variations of blood pressure before the examination. Investigations did not reveal a secondary cause of hypertension. After the physical examination and establishing the diagnosis of neurofibromatosis, as well as the history of symptomes suggestive of catecholamine discharge, diagnostic procedures for pheochromocytoma were undertaken. Abdominal CT and MRI have proven the presence of a right adrenal tumor mass which was suspected to be a pheochromocytoma. Patient was preoperatively treated for two weeks with alpha and beta blokers and right adrenalectomy was performed. Perioperatively and on a longer term, blood pressure remained well controlled with less antihypertensive therapy. Diagnosis and management of pheochromocytoma in neurofibromatosis involves a dermatologist, endocrinologist, nephrologist and an urologist and requires a well-coordinated multidisciplinary approach., Conclusions: Pheochromocytoma, although a rare condition in patients with neurofibromatosis, may be a cause for uncontrolled hypertension, as well as other cardiovascular complications and the clinician should do all available clinical investigations to confirm it or exclude it on time.
- Published
- 2015
- Full Text
- View/download PDF
17. Protocol for performing nephrological activity in the Republic of Macedonia.
- Author
-
Polenakovic M, Bogdanovska S, Cakalaroski K, Dzikova S, Masin G, Masin-Spasovska J, Oncevski A, Gerasimovska V, Spasovski G, Grozdanovski R, Stojceva-Taneva O, Grcevska L, Sikole A, Dejanov P, Tozija L, Zafirovska K, Ivanovski N, Lozance L, and Pusevski V
- Subjects
- Humans, Republic of North Macedonia, Kidney Diseases therapy, Nephrology methods
- Abstract
The fast development of nephrology in the world, especially in the second half of the 20 th century demanded protocol (guidelines) for nephrological activity for all levels of medical care, of doctors and specialists. The International Society of Nephrology, the European Renal Association and other national associations created their own protocol (guidelines) for nephrological activity. The Macedonian Society of Nephrology, Dialysis, Transplantation and Artificial Organs (MSNDTAO) proclaimed the First Protocol for Performing Nephrological Activity in the Republic of Macedonia at the First Congress of the MSNDTAO, held in Ohrid 1993, and it was published in the Macedonian Medical Review, 1994; Supplement 14: 397-406 [1]. The update of the Protocol for Performing Nephrological Activity in the Republic of Macedonia was proclaimed at the Fourth Congress of MSNDTAO, held in Ohrid 2012 and it presented in this text.
- Published
- 2014
- Full Text
- View/download PDF
18. Risk factors and outcome of Preeclampsia.
- Author
-
Gerasimovska-Kitanovska B, Zafirovska K, Bogdanovska S, and Lozance Lj
- Subjects
- Adult, Female, Humans, Pre-Eclampsia therapy, Pregnancy, Prenatal Care, Prospective Studies, Risk Factors, Pre-Eclampsia epidemiology, Pregnancy Outcome epidemiology
- Abstract
Aim: To determine differences between groups with hypertension in pregnancy and assess risk factors associated with preeclampsia., Patients and Methods: In the period 2008-10 at the Department of Nephrology in Skopje, Macedonia, a prospective and a longitudinal study study comprising 134 pregnant women was carried out. They had regular monthly check-ups in pregnancy and after delivery (1-8), when groups were defined as gestational hypertension, pre-existing hypertension, superimposed preeclampsia, and preeclampsia. A total of 134 women were regularly controlled by 24-hour ambulatory monitoring of blood pressure (24ABPM), blood and urine, D-dimers, and a resistance index of the Doppler of the umbilical artery (RI a.umb), and a questionnaire on risk factors was filled in for every pregnant woman., Results: Superimposed preeclampsia was found in 22 (16.4%) and preeclampsia was found in 20 women (14.9%). Daily diastolic blood pressure of 24-hour blood pressure monitoring at the last check-up before delivery was significantly higher in the group with superimposed preeclampsia (SP) 87.6±9.5 and in the group with preeclampsia (PE) 87.9±7.7 mm Hg. Previous preeclampsia (OR=3.28), primiparity (OR=2.35), methyldopa (OR=3.76), number of check-ups (OR=2.3), positive family history (OR=1.4) and in vitro fertilisation (OR=1.15) were found as risk factors associated with the occurrence of preeclampsia and preeclampsia superimposed on preexisting hypertension., Conclusions: Early determination of risk factors should prompt more frequent check-ups in hypertensive pregnancies in order to determine timely delivery and avoid adverse outcomes in the mother and child.
- Published
- 2010
19. [Association of moderate alcohol intake, blood pressure regulation and renal function].
- Author
-
Gerasimovska-Kitanovska B, Zafirovska K, Bogdanovska S, and Lozance L
- Subjects
- Body Mass Index, Creatinine metabolism, Female, Humans, Hypertension physiopathology, Male, Middle Aged, Alcohol Drinking, Blood Pressure, Kidney physiology
- Abstract
Aim: to determine differences in regulation of blood pressure and renal function in patients with moderate intake of alcohol (1-14 units per week)., Material and Methods: Cross-section study performed at the Department of Nephrology. Seventy-six patients admitted for diagnosis and treatment of hypertension were included. Patients with diabetes mellitus, renal failure and other coorbidities were excluded from the study. Medical history, data on alcohol consumption, laboratory analysis, Doppler echosonography of intrarenal blood vessels and 24-hour blood pressure monitoring were performed. The group that consumed alcohol (A+) consisted of 10 patients, while the group that did not (A-) consisted of 66 patients. The two groups were comparable by age, BMI and hypertension history. Two groups were compared by the values of their blood pressure, BMI, hypertension history in months, serum creatinine, uric acid, Doppler duplex index of renal resistence, triglycerides and cholesterol., Results: In group A+ , the serum creatinine was significantly higher, but still within the normal range (86.3+/-15.72 vs 71.75+/-14.77, p=0.005). Serum uric acid followed the same trend (360.3+/-110.18 vs. 284.4+/-95.28, p=0.026. Pulse pressure and mean arterial pressure were higher in the A+ group (71.33+/-19.23 vs. 57.65+/-16.78, p=0.028 and 127.81+/-17.6 vs 111.02+/-21.67, p=0.03 respectively). Serum lipids were unsignificantly higher in the A+ group (9.56+/-1.5 vs 9.02+/-1.59, p=0.38). No changes between groups were registered with Doppler sonography of intrarenal blood vessels. In women, consumption of alcohol was associated with blood pressure control., Conclusion: Moderate alcohol consumption is associated with the regulation of the blood pressure.
- Published
- 2007
20. Decreased nitric oxide in women with essential hypertension in prehypertensive phase.
- Author
-
Gerasimovska-Kitanovska B, Zafirovska K, Bogdanovska S, Lozance L, and Severova-Andreevska G
- Subjects
- Adult, Case-Control Studies, Cross-Sectional Studies, Female, Humans, Hypertension metabolism, Time Factors, Vasoconstriction, Vasodilation, 6-Ketoprostaglandin F1 alpha analysis, Hypertension physiopathology, Nitric Oxide blood, Thromboxane B2 blood
- Abstract
Aim: To determine the concentrations of nitric oxide (NO) in plasma of women with essential hypertension in prehypertensive phase, its effect on blood pressure, and correlation with other vasoactive substances that regulate systemic and renal vascular tonus., Methods: The study performed at the Department of Nephrology, Hospital Center in Skopje, Macedonia, included 26 women with essential hypertension in prehypertensive phase and 11 normotensive women as healthy controls. Vasodilating factors NO and 6-keto-prostaglandin F1 alpha (6-keto-PGF1alpha) were determined in plasma. Thromboxane B2 (TXB2) as a vasoconstricting factor and electrolytes Na+, K+, and Ca2+ were determined in urine. Blood pressure was monitored over 24 hours. Systolic, diastolic, mean blood pressure were presented as average 24-hour values., Results: The concentrations of NO and 6-keto-PGF1alpha were significantly lower in women with essential hypertension in prehypertensive phase than in their normotensive controls (NO: median 22, range 11-35 vs median 37.5, range 11-66; 6-keto-PGF1alpha: 64.8+/-14.35 vs 98.21+/-43.45 micromol/L; P<0.001). The index of vascular reactivity (TXB2/6-keto-PGF1alpha ratio) was higher in women in prehypertensive phase than in normotensive women (1.3 vs 0.8, P<0.001). Urinary calcium to creatinine ratio was significantly lower in the prehypertensive group (0.06+/-0.03 vs 0.24+/-0.13, P<0.001). No direct correlations were found between NO, TXB2, and 6-keto-PGF1alpha, or between NO and electrolytes in the urine. Low NO and urinary Ca2+ were significant indicators of increased blood pressure (P=0.013 and P=0.024, respectively; backward stepwise multiple regression analysis)., Conclusions: NO and 6-keto-PGF1alpha were significantly lower in women in prehypertensive phase of essential hypertension. Lower NO correlated with increased systolic blood pressure, but not with on natriuresis and calciuresis. These findings, together with the higher vascular reactivity index, indicate that endothelial dysfunction precedes the establishment of essential hypertension.
- Published
- 2005
21. Changes of plasma fibronectin levels in pregnancy induced hypertension.
- Author
-
Paneva-Masin J, Zafirovska K, Bogdanovska S, Lozance L, and Gerasimovska B
- Subjects
- Adult, Chronic Disease, Female, Humans, Pre-Eclampsia blood, Pregnancy, Prospective Studies, Fibronectins blood, Hypertension blood, Pregnancy Complications, Cardiovascular blood
- Abstract
A number of laboratory tests are available for evaluation of hypertension in pregnancy. These tests can be used to either predict and/or prognosticate preeclampsia and other hypertensive disorders of pregnancy. The aim of this study was to evaluate alterations in fibronectin homeostasis in normotensive pregnancy and in hypertensive disorders of pregnancy subclassified into chronic hypertension, preeclampsia superimposed on chronic hypertension, and pregnancy induced hypertension. A prospective, longitudinal study was conducted in 115 pregnant women aged 20-39 years, divided into four groups: normotensive (n = 40), chronic hypertension (n = 18), preeclampsia superimposed on chronic hypertension (n = 20), and pregnancy induced hypertension (n = 37). Plasma concentrations of fibronectin were measured by using single radial immunodiffusion assay (RIA) in the 8th, 18th, 23rd, 28th, 32nd and 36th week of gestation. Plasma fibronectin concentration showed no significant changes in normotensive pregnancy, but was significantly elevated in the third trimester in women destined to become preeclamptic or with preeclampsia in whom it reached a mean (+/- SD) of 0.40 +/- 0.09 g/L in the 36th week of gestation. In the groups with preeclampsia superimposed on chronic hypertension and with pregnancy induced hypertension, there was a significant difference between plasma fibronectin concentrations in 32nd (p < 0.01) and 36th (p < 0.001) week of gestation compared with either other levels in the respective group (in the 8th, 18th, 23rd and 28th week of gestation) or those recorded in other groups in the same period of pregnancy. These results suggested that the measurement of plasma fibronectin might be of diagnostic value in preeclampsia but could not be considered a useful predictor for preeclampsia.
- Published
- 2000
22. Renal dysfunction and early differences in twenty-four-hour ambulatory blood pressure monitoring in subjects predisposed for essential hypertension.
- Author
-
Lozance L, Zafirovska K, Bogdanovska S, and Masin-Paneva J
- Subjects
- Adult, Humans, Hypertension diagnosis, Hypertension physiopathology, Blood Pressure Monitoring, Ambulatory, Hypertension genetics, Kidney physiopathology
- Abstract
In 24 young normotensive subjects (mean age 22.25 +/- 5.65 years) with one hypertensive parent (FH(+)-), 22 subjects (mean age 23.55 +/- 5.17 years) with two hypertensive parents (FH+ +/-), and a control group of 16 age and gender matched subjects (mean age 22.50 +/- 6.00 years) with two normotensive parents (FH--), creatinine clearances and microalbuminuria (MA) were measured. Blood pressure was monitored for 24 hours and mean arterial pressure (MAP) was calculated and compared between groups. No significant differences were recorded. FH(+)- and FH++ subjects had significantly higher MAP over the sleeping period than FH-- subjects (78.63 +/- 1.71, 78.95 +/- 1.27; and 72.91 +/- 1.35 mmHg respectively; p < 0.02). Creatinine clearance was higher in FH(+)- and FH++ group compared to FH-- subjects (2.39 +/- 0.17; 2.29 +/- 0.17; and 1.66 +/- 0.11 ml/sec respectively; p < 0.01). Hyperfiltration correlated with MAP in FH++ subjects (2.29 +/- 0.17 ml/sec; 92.45 +/- 7.39 mmHg; r = 0.52 i p < 0.03). MA correlated neither with creatinine clearance nor with MAP. Our results suggest that hypertension may develop as a consequence of the long-lasting, higher GFR, which may accelerate the age-related process of sclerosis both in the small arterioles and the glomeruli.
- Published
- 1996
23. [Serum levels of uric acid, lipids and glucose in essential hypertension].
- Author
-
Bogdanovska S, Zafirovska K, Lozance Lj, and Masin-Paneva J
- Subjects
- Adult, Humans, Male, Blood Glucose analysis, Hypertension blood, Lipids blood, Uric Acid blood
- Abstract
In 48 men, 42, 1 +/- 8.8 yrs old, with untreated mild essential hypertension, serum uric acid, total cholesterol triglycerides and glucose were examined at 8 a.m after 16 hour overnight fasting. All patients were overweight, with body mass index: 26.9 +/- 2.4 kg/m2, (normal value: 19-24.9); serum uric acid 293.1 +/- 89.3 mmol/l; cholesterol 6.3 +/- 1.4; triglycerides 2.0 +/- 1.3 and glucose 5.4 +/- 0.9 mmol/l. File out of 48 (10.4%) patients had hyperuricemia, nine (18.7%) had hypercholesterolemia, twenty (41.7%) had hypertriglyceridemia and 19 (39.6%) had hyperglycemia. Significant correlation between serum uric acid and triglycerides only (r = 0.35; p < 0.01), was found. A correlation exists between the diastolic blood pressure and cholesterol (r = 0.35; p < 0.01); as well as, between mean arterial blood pressure and cholesterol (r = 0.34; p < 0.02). Only three out of 48 (6.2%) patients with hypertension had all four biochemical parameters above normal levels. Our results suggest that interrelation of all these metabolic disorders are important in essential hypertension, and especially the association of high serum uric acid and triglyceride level.
- Published
- 1996
24. Changes of endothelin-1 level in normotensive pregnancy and in preeclampsia.
- Author
-
Maleska V, Zafirovska K, Tofoski J, Lozance L, and Bogdanovska S
- Subjects
- Adult, Biomarkers blood, Endothelin-1 biosynthesis, Female, Humans, Linear Models, Pre-Eclampsia blood, Pre-Eclampsia prevention & control, Predictive Value of Tests, Pregnancy, Prospective Studies, Reproducibility of Results, Sensitivity and Specificity, Endothelin-1 blood, Pre-Eclampsia diagnosis
- Published
- 1996
- Full Text
- View/download PDF
25. Primary disseminated form of Ewing sarcoma in association with hypercalcemia and acute renal failure.
- Author
-
Lozance LA, Zafirovska KG, Bogdanovska SV, and Zafirovski GJ
- Subjects
- Acute Kidney Injury pathology, Adult, Glomerular Filtration Rate physiology, Humans, Hypercalcemia drug therapy, Hyperparathyroidism, Secondary etiology, Indomethacin therapeutic use, Kidney pathology, Male, Parathyroid Hormone metabolism, Prostaglandins E metabolism, Acute Kidney Injury etiology, Hypercalcemia etiology, Sarcoma, Ewing complications
- Abstract
We present a case of an extremely rare form of Ewing sarcoma--primary disseminated, with fulminating course, severe hypercalcemia, extensive calcium deposition in parenchymatous organs, including kidneys, and acute renal failure as a clinical consequence. Correction of hypercalcemia was followed by prompt restoration of the glomerular filtration rate (GFR), suggesting that hypercalcemia had a direct effect on its regulation independent of the renal tubular damage. The effectiveness of the treatment with indomethacin indirectly supports the possibility of prostaglandin-mediated humoral hypercalcemia of malignancy.
- Published
- 1994
- Full Text
- View/download PDF
26. Urinary excretion of three specific renal tubular enzymes in patients treated with nonsteroidal anti-inflammatory drugs (NSAID).
- Author
-
Zafirovska KG, Bogdanovska SV, Marina N, Gruev T, and Lozance L
- Subjects
- Anti-Inflammatory Agents, Non-Steroidal adverse effects, CD13 Antigens, Glomerular Filtration Rate, Humans, Kidney Diseases chemically induced, Kidney Diseases diagnosis, Kidney Diseases urine, Middle Aged, Osteoarthritis drug therapy, Time Factors, Acetylglucosaminidase urine, Aminopeptidases urine, Anti-Inflammatory Agents, Non-Steroidal therapeutic use, gamma-Glutamyltransferase urine
- Abstract
Ten patients, mean age 51.50 +/- 3.03 years, with degenerative rheumatism on NSAID treatment without any sign of renal disease, and 11 control subjects, mean age 43.50 +/- 1.51 years, were studied. NSAID treatment was of 11.30 +/- 5.60 weeks duration in average, with ibuprofen, naproxen, or indomethacin. Urinary excretion of three specific renal tubular enzymes--AAP: alanine-amino-peptidase, GGT: gamma-glutamyl-transpeptidase, and beta-NAG: beta-N-acetyl-glucosaminidase, were determined in 8-h overnight urine samples, as well as GFR creatinine clearance/1.73 m2, urinary volume/8 h, specific gravity of the urine, proteinuria and glucosuria. In the group treated with NSAIDs, urinary excretion of the enzymes was significantly higher than in the control group--AAP: 1414.20 +/- 317.60, 864.20 +/- 94.42, p < 0.00001; GGT: 8034.6 +/- 1378.55, 5095.64 +/- 614.40, p < 0.00001, and beta-NAG: 1644.60 +/- 299.97, 964.82 +/- 142.00, p < 0.00001. Patients on NSAID treatment showed abnormal urinary excretion of AAP in 7/10 cases, of GGT in 6/10, and of beta-NAG in 7/10 cases. Duration of the treatment did not correlate with the urinary excretion of the enzymes. Age was in correlation with the urinary excretion of the enzymes only in the control group, r = 0.52, p < 0.005 for AAP, r = -0.43, p < 0.02 for GGT, and r = -0.23, p < 0.05 for beta-NAG.(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1993
- Full Text
- View/download PDF
27. [Etiologic correlation between the vaginal vestibule, the urethra and the bladder in recurrent urinary infections].
- Author
-
Bogdanovska S
- Subjects
- Adult, Female, Humans, Male, Middle Aged, Recurrence, Urethra microbiology, Urinary Bladder microbiology, Urinary Tract Infections microbiology, Vagina microbiology
- Published
- 1978
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.